141. Lymphoma Genomics At The Bedside - Cancer: Health And Medical Information About OncoLink The Web s First Cancer Resource Types of Cancer. Types of Cancer lymphomas. lymphomas. AIDSrelated lymphoma. CutaneousT-Cell lymphoma/Mucosis Fungoides. Hodgkin s Disease. Non-Hodgkin s Disease. http://c.moreover.com/click/here.pl?r150129573

142. Case 11--Mantle Cell Lymphoma Mantle Cell lymphoma (Previous terms centrocytic lymphoma, lymphocyticlymphoma of intermediate differentiation, mantle zone lymphoma 13). http://pathhsw5m54.ucsf.edu/case11/mcl.html

Mantle Cell Lymphoma (Previous terms: centrocytic lymphoma, lymphocytic lymphoma of intermediate differentiation, mantle zone lymphoma [1-3]) Introduction: Mantle cell lymphoma (MCL) is a rare type of lymphoma (5-10% of all malignant lymphomas [1, 2]). The normal cellular counterpart is a B cell found in small numbers in the mantle zone of lymphoid follicles (see diagram below) [1, 4]. MCL was originally classified as a low-grade lymphoma, but recent reports of outcome indicate that most cases behave as an intermediate-grade lymphoma. It has neither the long survival of low-grade tumors nor the response to aggressive chemotherapy of high-grade tumors. One exception is the infrequent "mantle zone" variant, which may have a more indolent course [1, 2]. Clinical features: Histologic changes: This tumor is difficult to diagnose histologically. Furthermore, four types have been described (see figure). Cells are small- to medium-sized lymphocytes with irregularly-shaped nuclei, small nucleoli, and scant cytoplasm. The frequency of each type varies somewhat with the series [2]. Immunologic and molecular features distinguish this lymphoma from others. Cells express the pan-T-cell antigen CD5, surface IgM and IgD, and pan-B-cell antigens CD 19, CD 20, and CD 22. Figure: Each of the circles below illustrates a subtype of MCL.

143. Ivanhoe's Medical Breakthroughs - Lymphoma Vaccine lymphoma Vaccine. That s the unfortunate thing about nonHodgkin s lymphoma B-cells,is that the patient just has to wait and see what happens, Steeves says. http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=8370

144. Allthingspossible.org Provides a record of a new mother's struggle with a rare form of this disease including links to related cancer resources. http://allthingspossible.org

"..with God all things are possible" - Matthew 19:26 NIV Cancer Resources Archives Photos Megan began having unexplained fevers, night sweats, and enlarged lymph nodes weeks after giving birth to Diana. A lymph node biopsy and CT scans revealed widespread cancer of her immune system. These pages record Megan's heroic struggle with a rare form of non-Hodgkin's Lymphoma, chemotherapy, and a peripheral stem cell transplant; the overwhelming love and prayers of people around the world; and her unwavering faith in God. News The Raleigh News and Observer published a two-part tribute to Megan in their newspaper on Sunday, June 23rd and Monday, June 24th. Staff Writer Sarah Avery and Photographer Susana Vera followed Megan's story since January 2002 after first reporting on a bone marrow drive held in her honor at White Plains United Methodist Church in Cary, North Carolina. allthingspossible.org

145. Lymphoma (follicular Non-Hodgkin's) - Rituximab (no. 37) Up. Down. lymphoma (follicular nonHodgkin s) - rituximab (no. 37). 2002/018 NICErecommends the selective use of rituximab for follicular non-Hodgkins lymphoma, http://www.nice.org.uk/cat.asp?c=29983

146. Children's Leukemia Foundation Of Michigan Statewide organization which provides information, financial assistance, and emotional support to families of adults and children affected by leukemia, lymphoma, and other related blood disorders. http://www.leukemiamichigan.org/

147. SF AIDS Fdn: BETA 1/98 -- AIDS-Relatated Lymphoma 98 Bulletin of Experimental Treatments for AIDS covers AIDSrelated lymphoma, atype of cancer in which the cells of the lymphoid tissue multiply unchecked. http://www.sfaf.org/treatment/beta/b35/b35lymp.html

Published in the Bulletin of Experimental Treatments for AIDS January 1998 issue, by the San Francisco AIDS Foundation. January 1998 Table of Contents Main Page beta@sfaf.org AIDS-Related Lymphoma By Mark Bowers Lymphoma is a type of cancer in which the cells of the lymphoid tissue multiply unchecked. Lymphomas are divided into 2 categories: Hodgkin's lymphoma, if a type of cells called Reed-Steinberg cells are present, or non-Hodgkin's lymphoma (NHL). The rate of NHL rose steadily among people with AIDS from 1989 to 1995. Research increasingly points to cooperation between or among viruses to produce this kind of cancer. However, clinical research on AIDS-related lymphoma in the brain is sadly lacking. Incidence Non-Hodgkin's lymphoma (previously called lymphosarcoma) is a type of cancer that affects cells found mainly in the lymph nodes and the spleen. Leukemia and lymphoma are the common names for cancer of the white blood cells. Cancer can transform any white blood cell at any stage in the progression from bone marrow stem cells to mature T-cells and B-cells. NHL can arise at any stage of HIV disease. The rate at which people with AIDS develop NHL continued to rise until 1995, when highly active antiretroviral therapy (HAART therapy combining more than one class of anti-HIV drugs) began to become widespread. The increased number of people with HIV and NHL apparently was proportional to the extent and duration of suppression of their immune systems.

148. EMedicine: B-Cell Lymphoma - Type B Non-Hodgkin Lymphoma : Article By Ajeet Gajr Oncologist's report includes an indepth review of this condition. http://www.emedicine.com/med/topic1358.htm

(advertisement) Home Specialties Resource Centers CME ... Patient Education Articles Images CME Patient Education Advanced Search Consumer Health Link to this site Back to: eMedicine Specialties Medicine, Ob/Gyn, Psychiatry, and Surgery Hematology Lymphoma, B-Cell Last Updated: July 25, 2002 Rate this Article Email to a Colleague Synonyms and related keywords: non-Hodgkin lymphoma, NHL, lymph node, lymphoid tissue, indolent lymphomas, aggressive lymphomas, Burkitt lymphoma, lymphoblastic lymphoma, B-cell neoplasms, T/NK-cell neoplasms, Hodgkin lymphoma, Hodgkin's lymphoma, B-cell chronic lymphocytic leukemia, CLL, B-cell small lymphocytic lymphoma, lymphoblastic lymphomas, T-cell acute lymphocytic leukemias, diffuse large B-cell lymphoma, follicular lymphoma, follicular large cell lymphoma, mantle cell NHL, small lymphocytic lymphoma, B-cell CLL, splenic marginal zone lymphoma, extranodal B-cell lymphoma of mucosa-associated lymphoid tissue, MALT, mediastinal diffuse large B-cell lymphoma AUTHOR INFORMATION Section 1 of 11 Author Information Introduction Clinical Differentials ... Bibliography Author: Ajeet Gajra, MD

149. Lymphoma Program lymphoma Program. The University of Nebraska Medical Center is worldrenowned for the diagnosis, therapy, and research of lymphoma. http://www.unmc.edu/lymphoma/

Lymphoma Home Lymphoma Team Research Studies Lymphoma Study Group ... UNMC Home Lymphoma Program The University of Nebraska Medical Center is world renowned for the diagnosis, therapy, and research of lymphoma. Lymphomas are malignancies of the lymphatic system. Lymphomas are broadly classified into Hodgkin's disease and non-Hodgkin's Lymphoma. Each year more than 65,000 Americans are diagnosed with lymphomas. Lymphomas are caused by growth of malignant lymphocytes in the lymph nodes and other tissues in the body. Patients with lymphoma who come to UNMC may live locally or may be referred to us from all across the country and other continents. Patients come for consultation, initial diagnosis, standard chemotherapy, participation in clinical research trials, or bone marrow/stem cell transplant (autologous or allogeneic).

150. Caltri: Bath Cancer Research - Drug Sensitivity Testing For Cancer, Leukaemia An Offers drug cytotoxicity screening, ex vivo drug sensitivity studies for leukaemias and lymphoma, to consultants, as an international service from a charitably funded research group at the Royal United Hospital. http://caltri.org/

B ath C ancer R esearch Bath Cancer Research DiSC assay for CLL endorsed by US government panel If you are a patient, please read....... For Patients For Clinicians Contact Request Form Funding Research Scientists at Bath Cancer Research undertake ex vivo drug sensitivity studies using the Differential Staining Cytotoxicity (DiSC) assay [Ref 10 of Selected Publications ]. With this we assess the cytotoxic drug sensitivity of fresh human cells from patients with leukaemia, lymphoma and cancer. Our greatest expertise is with chronic lymphocytic leukaemia (CLL), acute myeloid leukaemia (AML or ANLL) and non-Hodgkin's lymphoma. Service Bath Cancer Research also provides an international service for consultant haematologists/ oncologists, testing cells from their patients for ex vivo drug response to a panel of cytotoxic drugs (up to 35 drugs). A report is sent to the physician to aid choice of optimum therapy. This information helps maximise the likelihood of response (and therefore survival) and reduces the risk of causing patient toxicity with no clinical benefit. Some assays are chargeable New Drug Screening Bath Cancer Research tests new cytotoxic agents in "Ex vivo Phase II trials" (Ref 14 of

151. Lymphoma Protocol Comparison Treatment of lymphoma in Dogs A Comparison of Three Chemotherapy Protocols. MatusRE. Chemotherapy of lymphoma and leukemia. In Kirk RW, Bonagura JD, eds. http://www.vin.com/oncology/html/default_lymphoma_protocol_comparison.html

Treatment of Lymphoma in Dogs: A Comparison of Three Chemotherapy Protocols Lymphoma is a common malignancy of dogs, and is the neoplastic disease most commonly treated with chemotherapy in veterinary medicine. A wide variety of single agent and combination chemotherapy protocols have been evaluated for the treatment of lymphoma in dogs. There is, however, no consensus among veterinary oncologists as to whether an "ideal" protocol has yet been developed. Single Agent Therapy Prednisone, cyclophosphamide, doxorubicin, epirubicin, cytosine arabinoside, and actinomycin-D are among the drugs that have been evaluated as single agents for the treatment of lymphoma in dogs. Of these, doxorubicin seems to be the most effective single agent. The overall response rate (partial and complete response) has been reported to be 81% with median remission and survival times of 131 and 230 days, respectively. Doxorubicin has also been reported to be effective in inducing a second remission in dogs previously treated with combination chemotherapy. Combination Chemotherapy Resistance of cancer cells to chemotherapuetic agents is a major obstacle to the effective treatment of cancer in both veterinary and human medicine. While we have yet to overcome all the problems of drug resistance in the treatment of lymphoma, the use of a combination of chemotherapuetic agents is an important step in addressing this problem. Within a population of cancer cells, the probability of the development of resistant clones is directly related to cell number. At the time of diagnosis, it is probable that the population of lymphoma cells in a canine patient contains several cell lines that are resistant to one or more chemotherapuetic agents. Combination chemotherapy accomplishes three goals that are not possible with single agent therapy: First, because each drug is given at it

152. Information On Non Hodgkins Lymphoma Cancer. Articles And Videos About Non Hodgk Primarily oriented to treatment using radioimmunotherapy. Sponsored by the IDEC Pharmaceuticals firm. http://www.lymphomainnovations.com

Lymphoma Innovations Targeted Information for Patients With Non Hodgkins Lymphoma Welcome Lymphoma Innovations offers information on advanced treatments for Non Hodgkins lymphoma (NHL). Traditional chemo- and radiation therapy may succeed in destroying cancer cells, but they kill lots of healthy cells in the process. Today, a newer class of drugs is harnessing the immune system to fight Non Hodgkins lymphoma while sparing normal tissues. When tagged with radioactive substances, they're part of radioimmunotherapy, one of the most potent weapons yet in the fight against Non Hodgkins Lymphoma. Lymphoma Innovations will keep you apprised of new developments in this promising line of attack against cancer. Your quality of care and quality of life are our top concern. Sign up for Lymphoma updates Email: I prefer to receive updates in the following format: Text HTML Please send me general health updates Understanding Radioimmunotherapy Radioimmunotherapy and NHL Related Articles Related Links ... Contact Us Supported through an educational grant from Biogen Idec

153. Joseph D Helmuth Memorial Golf Classic Benefits the Helmuth Educational Fund and the lymphoma Foundation. Includes image gallery with information on sponsors, registration and outing details. http://helmuthfund.com/index.html

154. Pharmaceutical Research And Manufacturers Of America New Medicines in Development. lymphoma. Complete a new search Drug Name (Proprietaryname/Generic name). ASI BCL ASI BCL / none. lymphoma. INSMED Richmond, VA. http://www.phrma.org/newmedicines/newmedsdb/drugs.cfm?indicationcode=Lymphoma|17

155. Follicular Lymphoma Survival, Non-Hodgkins Lymphoma Cancer Treatment Information about this rare condition including treatment and care strategies from a survivor. http://www.lymphomasurvival.com/

Home About Me Articles Testimonials ... How To Receive Articles There is life after lymphoma...lots of it! This site is devoted to the achievement of long-term survival by providing educational material to patients and care-givers who wish to participate in managing the disorder known as follicular lymphoma (fNHL), specifically grades one and two. Here are the important things a person needs to know, scientifically based, easily understood and straight to the point. My name is Robert G. Miller. Diagnosed with nodular (follicular) and diffuse lymphoma in July 1988, I'm currently well and fully active. For more information please see About me Follicular lymphoma is a confusing disorder...often in the initial stages a benign-like tumor, much different than other forms of cancer, where the person has no symptoms and "watchful waiting" is suggested. On the other hand, the individual may be counseled to try for a cure and be subjected to some of the most potent chemotherapy drugs on the shelf. In the end, no treatment yet devised has proven to be curative. As prominent lymphoma specialist Dr. Alexandra Levine has noted, "Ask 5 hematologists how to treat newly diagnosed follicular lymphoma and, chances are, at least 2 or 3 different and equally viable regimens will be mentioned”.

156. Stop Non-Hodgkin's Lymphoma Learn what you can do to help stop nonhodgkin s lymphoma. Also, a lymphomalinks. Click here to break out of frames. Non-Hodgkin s lymphoma. http://www.geocities.com/Heartland/Valley/6727/stopNHL/

Click here to break out of frames Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma (NHL) is a disease which originates in the lymphatic system. It was once considered a fairly rare type of cancer, however it's now moved into place as being the second most rapidly increasing cancer in the United States. Some experts even refer to it as the "NHL epidemic". Since 1973, the incidence rate for non-hodgkin's lymphoma has nearly doubled! Lymphoma has the second highest mortality rate of any cancer. I invite you to join me in my fight to stop non-hodgkin's lymphoma. What You Can Do Suggestions on things you can personally do to help stop non-hodgkin's lymphoma. Updated 11/01/02 Fund Raising Events Fund raising events to benefit research for non-hodgkin's lymphoma. Updated 9/10/03 NHL Prayer List Please pray for the people on this list! Updated 5/31/04 Stop NHL Message Board A message board for anyone who has had their life touched by non-hodgkin's lymphoma ~ patients, family, or friends. New messages daily Walking By Faith Forum A message board for Christians who have had their lives touched by non-hodgkin's lymphoma ~ patients, family, or friends.

157. Laboratories Microflow Litron Labs Home A genetic toxicology testing laboratory performing Ames, lymphoma, CHO assays, and flow cytometric micronucleus tests, marketed as MicroFlow. http://www.litronlabs.com/

158. AEGiS-NMAIN: Lymphoma (NHL) A nontechnical fact sheet on lymphoma, an opportunistic infectionrelated to HIV disease. WHAT IS lymphoma? lymphoma refers to http://www.aegis.com/pubs/nmap/509-lymphoma.html

Lymphoma (NHL) New Mexico AIDS InfoNet - Revised May 4, 2001 WHAT IS LYMPHOMA? HOW IS NHL DIAGNOSED? WHAT CAUSES NHL? HOW IS NHL TREATED? ... THE BOTTOM LINE Print this Fact Sheet on a single page using: Microsoft Word Adobe Acrobat WHAT IS LYMPHOMA? Lymphoma refers to cancers that involve a type of white blood cell. Cells called B-lymphocytes multiply rapidly and form tumors. These can occur in the lymph nodes, bone marrow, intestines, or spinal cord. Lymphoma of the brain or spinal cord is called central nervous system (CNS) lymphoma. The longer you live with a suppressed immune system, the more likely you are to develop NHL. It is serious and fatal, often within a year. NHL is usually associated with long-term HIV disease and low CD4 counts. Combination antiviral therapy has significantly reduced the rates of most opportunistic infections. This is not true for NHL. HOW IS NHL DIAGNOSED? The first signs of NHL are swollen lymph nodes, fever, night sweats, and weight loss of more than 10%. These symptoms occur with several AIDS-related illnesses. If doctors cannot find another cause for these symptoms, they will test for NHL. NHL is usually diagnosed based on imaging techniques or biopsies. The imaging techniques can include various scans (CAT, PET, gallium and thallium.) Biopsies involve microscopic examination of cells from lymph nodes or other affected tissues.

159. University Of Michigan Comprehensive Cancer Center - Non-Hodgkin's Lymphoma Overview of the disease, symptoms and treatment plus information on clinical trials, support groups and CHOP. http://www.cancer.med.umich.edu/learn/nonhodg.htm

U-M Health System U-M Medical School U-M Gateway Hodgkin's and Non-Hodgkin's Lymphoma Information Education: Disease and Treatment Information Multidisciplinary Lymphoma Clinic main page Hodgkin's Lymphoma Non-Hodgkins Lymphoma Information on CHOP Clinical Trials Support Groups Non-Hodgkin's Lymphoma What is Non-Hodgkin's Lymphoma? What are the symptoms? What is the treatment? What is Non-Hodgkin's lymphoma? What are the symptoms? The most common symptom is a painless lump under the arms, in the neck or in the groin that persists for several weeks. Other symptoms may include fevers, night sweats, tiredness, weight loss, itching and reddened patches on the skin. Of course, these signs may also point to other, less serious problems. If you should develop any of them you should get a check-up, because only a doctor can tell for sure. Return to the top of the page What is the treatment?

160. Hematopathology Table Of Contents Now incorporating the WHO lymphoma classification. If You Have lymphomaThis site may be able to provide you with useful information. http://pleiad.umdnj.edu/hemepath/default.html

Now incorporating the WHO lymphoma classification. Introduction How to use this tutorial Benign Lymph Nodes Normal lymph nodes Specific reactions Non-Hodgkin's Lymphomas Overview of lymphomas Lymphoma classification Immunophenotyping B-cell lymphomas ... Mantle cell Non-Hodgkin's cont'd Follicular Diffuse large High grade T-cell lymphomas Hodgkin's Disease Overview of HD Types of HD Plasma Cell Neoplasms Types of disease If You Have Lymphoma: This site may be able to provide you with useful information. It is, however, primarily oriented to teaching medical professionals and interested lay people about the biology and diagnosis of lymphoma. Other sites are more geared toward telling people with lymphoma about the treatment and other aspects of their disease. Other Resources: Many other sites devoted to hematopathology and general pathology beckon the intrepid voyager. There are also many excellent books about hematological neoplasia. This site contains information that may help physicians and other health professionals understand lymphomas. It is not comprehensive and is likely not to contain information that may be important in treating individual patients. Patients with lymphomas must be cared for by qualified professionals familiar with the relevant clinical histories. Feedback: Please send any comments or suggestions via email If your system can only show 256 colors (8-bit color), a fair number of the photomicrographs will show some degradation. If possible, for best results set your monitor so that it can display High Color (16-bit color) or higher. Systems with at least 1 megabyte of video memory should be able to view High Color at an 800x600 resolution. The value of the text, of course, is independent of your monitor's ability to display colors.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 8     141-160 of 177    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8  | 9  | Next 20